Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 4
1991 12
1992 7
1993 22
1994 7
1995 15
1996 42
1997 13
1998 34
1999 35
2000 35
2001 30
2002 36
2003 44
2004 30
2005 46
2006 31
2007 52
2008 36
2009 33
2010 36
2011 40
2012 63
2013 50
2014 52
2015 55
2016 38
2017 47
2018 50
2019 75
2020 79
2021 97
2022 78
2023 59
2024 68
2025 62
2026 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,412 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Azithromycin for Poorly Controlled Asthma in Children: A Randomized Controlled Trial.
Ghimire JJ, Jat KR, Sankar J, Lodha R, Iyer VK, Gautam H, Sood S, Kabra SK. Ghimire JJ, et al. Chest. 2022 Jun;161(6):1456-1464. doi: 10.1016/j.chest.2022.02.025. Epub 2022 Feb 22. Chest. 2022. PMID: 35202621 Clinical Trial.
BACKGROUND: Azithromycin has immunomodulatory actions, and its beneficial effects have been demonstrated in asthmatic adults. ...INTERPRETATION: The use of azithromycin in children with poorly controlled asthma resulted in improved asthma control and reduced exacerb …
BACKGROUND: Azithromycin has immunomodulatory actions, and its beneficial effects have been demonstrated in asthmatic adults. ...INTE …
Azithromycin in patients with COVID-19: a systematic review and meta-analysis.
Ayerbe L, Risco-Risco C, Forgnone I, Pérez-Piñar M, Ayis S. Ayerbe L, et al. J Antimicrob Chemother. 2022 Feb 2;77(2):303-309. doi: 10.1093/jac/dkab404. J Antimicrob Chemother. 2022. PMID: 34791330 Free PMC article.
BACKGROUND: Azithromycin has been widely used in the management of COVID-19. However, the evidence on its actual effects remains disperse and difficult to apply in clinical settings. This systematic review and meta-analysis summarizes the available evidence to date on the …
BACKGROUND: Azithromycin has been widely used in the management of COVID-19. However, the evidence on its actual effects remains disp …
Azithromycin for acute bronchiolitis and wheezing episodes in children - a systematic review with meta-analysis.
Ukkonen RM, Renko M, Kuitunen I. Ukkonen RM, et al. Pediatr Res. 2024 May;95(6):1441-1447. doi: 10.1038/s41390-023-02953-z. Epub 2023 Dec 8. Pediatr Res. 2024. PMID: 38066246 Free PMC article.
CONCLUSIONS: We found moderate quality evidence that azithromycin may reduce hospitalization duration. Low certainty evidence suggests that azithromycin does not reduce the need for intensive care unit treatment. Furthermore, azithromycin did not prevent whee …
CONCLUSIONS: We found moderate quality evidence that azithromycin may reduce hospitalization duration. Low certainty evidence suggest …
Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
Uzun S, Djamin RS, Kluytmans JA, Mulder PG, van't Veer NE, Ermens AA, Pelle AJ, Hoogsteden HC, Aerts JG, van der Eerden MM. Uzun S, et al. Lancet Respir Med. 2014 May;2(5):361-8. doi: 10.1016/S2213-2600(14)70019-0. Epub 2014 Apr 15. Lancet Respir Med. 2014. PMID: 24746000 Clinical Trial.
We recorded 84 exacerbations in patients in the azithromycin group compared with 129 in those in the placebo group. The unadjusted exacerbation rate per patient per year was 1.94 (95% CI 1.50-2.52) for the azithromycin group and 3.22 (2.62-3.97) for the placebo grou …
We recorded 84 exacerbations in patients in the azithromycin group compared with 129 in those in the placebo group. The unadjusted ex …
Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis.
Horner P, Ingle SM, Garrett F, Blee K, Kong F, Muir P, Moi H. Horner P, et al. Sex Transm Infect. 2018 Feb;94(1):14-20. doi: 10.1136/sextrans-2016-053060. Epub 2017 Jul 17. Sex Transm Infect. 2018. PMID: 28717050 Review.
BACKGROUND: There is increasing evidence that azithromycin 1 g is driving the emergence of macrolide resistance in Mycoplasma genitalium worldwide. We undertook a meta-analysis of M. genitalium treatment studies using azithromycin 1 g single dose and azithromycin …
BACKGROUND: There is increasing evidence that azithromycin 1 g is driving the emergence of macrolide resistance in Mycoplasma genital …
Efficacy of azithromycin in treating Ureaplasma urealyticum: a systematic review and meta-analysis.
Fan W, Wang Q, Liang Z, Wang J, Zhang L. Fan W, et al. BMC Infect Dis. 2023 Mar 16;23(1):163. doi: 10.1186/s12879-023-08102-5. BMC Infect Dis. 2023. PMID: 36927441 Free PMC article.
The experimental group was treated with azithromycin monotherapy, while the control group was treated with doxycycline or a placebo. ...Subgroup analysis showed that the dose and duration of azithromycin may don't affect its efficacy. CONCLUSION: Regarding the meta- …
The experimental group was treated with azithromycin monotherapy, while the control group was treated with doxycycline or a placebo. …
Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.
O'Brien KS, Arzika AM, Amza A, Maliki R, Aichatou B, Bello IM, Beidi D, Galo N, Harouna N, Karamba AM, Mahamadou S, Abarchi M, Ibrahim A, Lebas E, Peterson B, Liu Z, Le V, Colby E, Doan T, Keenan JD, Oldenburg CE, Porco TC, Arnold BF, Lietman TM; AVENIR study group. O'Brien KS, et al. N Engl J Med. 2024 Aug 22;391(8):699-709. doi: 10.1056/NEJMoa2312093. N Engl J Med. 2024. PMID: 39167806 Clinical Trial.
METHODS: We randomly assigned rural communities in Niger to four twice-yearly distributions of azithromycin for children 1 to 59 months of age (child azithromycin group), four twice-yearly distributions of azithromycin for infants 1 to 11 months of age and pl …
METHODS: We randomly assigned rural communities in Niger to four twice-yearly distributions of azithromycin for children 1 to 59 mont …
Azithromycin vs penicillin G benzathine for early syphilis: A meta-analysis of randomized controlled trials.
Li Y, Jiang G. Li Y, et al. Dermatol Ther. 2020 Nov;33(6):e14025. doi: 10.1111/dth.14025. Epub 2020 Aug 26. Dermatol Ther. 2020. PMID: 32677163
This meta-analysis was conducted based on self-published randomized controlled trials (RCTs) data to compare the efficacy of azithromycin with penicillin for treating syphilis. RCTs on azithromycin vs penicillin for the treatment of syphilis were retrieved from the …
This meta-analysis was conducted based on self-published randomized controlled trials (RCTs) data to compare the efficacy of azithromycin …
Secondary Effects from Mass Azithromycin Administration: A Systematic Review and Meta-analysis.
Li J, Xiong T, Yue Y, Choonara I, Qazi S, Tang J, Shi J, Wang H, Qu Y, Mu D. Li J, et al. Am J Trop Med Hyg. 2022 Aug 15;107(4):904-911. doi: 10.4269/ajtmh.22-0134. Print 2022 Oct 12. Am J Trop Med Hyg. 2022. PMID: 35970284 Free PMC article.
The effects of azithromycin mass drug administration (MDA) on trachoma and yaws have been addressed. However, the secondary effects of azithromycin MDA remain unclear. ...The effect of azithromycin MDA on malaria was weak. No association was observed between …
The effects of azithromycin mass drug administration (MDA) on trachoma and yaws have been addressed. However, the secondary effects o …
Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials.
Oldenburg CE, Arzika AM, Amza A, Gebre T, Kalua K, Mrango Z, Cotter SY, West SK, Bailey RL, Emerson PM, O'Brien KS, Porco TC, Keenan JD, Lietman TM. Oldenburg CE, et al. Am J Trop Med Hyg. 2019 Mar;100(3):691-695. doi: 10.4269/ajtmh.18-0846. Am J Trop Med Hyg. 2019. PMID: 30608051 Free PMC article.
Mass drug administration (MDA) with azithromycin may reduce under-5 child mortality (U5M) in sub-Saharan Africa. Here, we conducted a pooled analysis of all published cluster-randomized trials evaluating the effect of azithromycin MDA on child mortality. ...There wa …
Mass drug administration (MDA) with azithromycin may reduce under-5 child mortality (U5M) in sub-Saharan Africa. Here, we conducted a …
1,412 results